Bottom line
How much do IBB and FBDIX overlap?
34% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 35.8% of IBB's assets and 23.0% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
IBB holds far more positions (254 vs 126), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and FBDIX have in common
| Holding | % of IBB | % of FBDIX | Overlap |
|---|---|---|---|
| Vertex Pharmaceuticals, Inc. | 7.66% | 3.54% | 3.54% |
| Gilead Sciences, Inc. | 7.52% | 3.86% | 3.86% |
| Amgen, Inc. | 7.50% | 4.39% | 4.39% |
| Regeneron Pharmaceuticals, Inc. | 5.70% | 3.77% | 3.77% |
| Argenx SE | 3.15% | 3.62% | 3.15% |
| Insmed, Inc. | 2.95% | 1.99% | 1.99% |
| Neurocrine Biosciences, Inc. | 1.34% | 1.82% | 1.34% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- Alnylam Pharmaceuticals, Inc. — 5.68%
- IQVIA Holdings, Inc. — 3.18%
- Mettler-Toledo International, Inc. — 2.49%
- Natera, Inc. — 2.11%
- BeOne Medicines Ltd. — 2.11%
- Biogen, Inc. — 2.03%
- United Therapeutics Corp. — 1.82%
- Waters Corp. — 1.77%
- Incyte Corp. — 1.62%
- Illumina, Inc. — 1.41%
- Genmab A/S — 1.38%
- Medpace Holdings, Inc. — 1.16%
- Exelixis, Inc. — 1.07%
- Ionis Pharmaceuticals, Inc. — 1.03%
Only in FBDIX
- Jazz Pharmaceuticals plc — 5.66%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
- Dianthus Therapeutics, Inc. — 2.32%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Praxis Precision Medicines, Inc. — 1.91%
- Spyre Therapeutics, Inc. — 1.87%
- Oruka Therapeutics, Inc. — 1.86%
- Bridgebio Pharma, Inc. — 1.67%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
- Franklin Institutional U.S. Government Money Market Fund — 1.45%
- Amylyx Pharmaceuticals, Inc. — 1.32%
Asset mix
| Asset type | IBB | FBDIX |
|---|---|---|
| Stocks | 99.8% | 97.0% |
| Cash & short-term funds | 13.4% | 4.6% |
| Preferred stock | — | 1.0% |
| Other | — | 0.6% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Country mix
| Country | IBB | FBDIX |
|---|---|---|
| US | 98.6% | 82.0% |
| IE | 0.5% | 6.7% |
| NL | 4.3% | 4.5% |
| CH | 2.7% | 1.2% |
| DK | 2.2% | 2.6% |
| FR | — | 1.7% |
| GB | 1.0% | 1.5% |
| CA | 0.6% | 1.3% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / Jul 31, 2026)
Check another pair
FAQ
How much do IBB and FBDIX overlap?
What stocks do IBB and FBDIX have in common?
Should I own both IBB and FBDIX?
Which holds more stocks, IBB or FBDIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.